Form 4: Repare Therapeutics EVP, CFO Steve Forte Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Forte, EVP and CFO of Repare Therapeutics Inc., sold 6,884 common shares on March 12, 2025, to cover tax obligations related to vesting restricted stock units.
Summary
- On March 12, 2025, Steve Forte, the EVP and CFO of Repare Therapeutics Inc., sold 6,884 common shares.
- The sale was executed at a price of $1.14 per share.
- The transaction was conducted to satisfy the reporting person's tax withholding obligation in connection with the vesting and settlement of restricted stock units.
- Following the transaction, Steve Forte directly owns 54,786 common shares of Repare Therapeutics Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
Executive stock sales to cover tax obligations are a common practice and don't necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The sale of shares could have a minor impact on shareholders due to the small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of transaction: Steve Forte sold 6,884 common shares. |
| 03/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.